Ivermectin shows promise as potential COVID-19 therapy.

Summary: An FDA-approved anti-parasitic drug called Ivermectin appears to inhibit and eliminate SARS-CoV-2 in lab-grown cell cultures within 48 hours. Ivermectin shows promise as potential COVID-19 therapy. However, researchers stress the need for further testing and clinical trials in humans to confirm the effectiveness of the drug and appropriate dosage levels.

Source: Monash University

Monash scientists have shown that an anti-parasitic drug already available around the world can kill the virus within 48 hours.

Scientists from the Biomedicine Discovery Institute (BDI) showed that a single dose of the drug, Ivermectin, could stop the SARS-CoV-2 virus growing in cell culture.

This Monash University-led collaborative study was published in Antiviral Research, a peer-reviewed medical journal Antiviral Research.

Whilst shown to be effective in the lab environment, Ivermectin cannot be used in humans for COVID-19 until further testing and clinical trials have been completed to confirm the effectiveness of the drug at levels safe for human dosing. The potential use of Ivermectin to combat COVID-19 remains unproven, and depends on funding to progress the work into the next stages.

Image Credit:  Amanda Scott/Alias/Envato

read the whole article

News This Week

Can We Stop a Super Coronavirus?

The new variants of the coronavirus are even more dangerous than those known so far. Researchers and politicians fear a sharp increase in the number of infections, with dramatic consequences like those seen in Britain. [...]

Could COVID-19 have wiped out the Neandertals?

Everybody loves Neandertals, those big-brained brutes we supposedly outcompeted and ultimately replaced using our sharp tongues and quick, delicate minds. But did we really, though? Is it mathematically possible that we could yet be them, [...]